RxDoctor Payments Data

Gregory Lundeen, MD

Foot and Ankle Surgery · Reno, NVNPI 1720036270

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $248,350 of the $301,436 with a category attached, or 82.4%. Stryker accounts for 78.9% of it on its own, with 34 other manufacturers making up the rest. Among foot and ankle surgery clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$301,436in general payments, 2019–2025

Across 368 payments — averaging $819.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$238K
  • Encore Medical, LP$34K
  • Trilliant Surgical LLC.$20K
  • Medshape, Inc.$4K
  • Exactech, Inc.$1K
  • Goode Surgical Inc$998
  • plus $4K from 29 others
$217,376in research payments, 2019–2025

Across 109 payments — averaging $1994.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biotissue Holdings Inc.$150K
  • Stryker$68K

What the payments were for

  • Consulting fees$248,35082%
  • Travel & lodging$38,16013%
  • Food & beverage$14,9265%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$301,436 in reported general payments places this provider in the 95th percentile of 84 foot and ankle surgery providers in Nevada.

See all foot and ankle surgery providers in Nevada

Medicare billing

Part B allowed, 2024
$279,267
Medicare patients
393
Services billed
1,883

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl240$1,283
Gabapentin256$1,176
Hydroxyzine Pamoate179$658
Pregabalin18$441
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen43$227
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$146
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim27$70
Cephalexin14$50
Meloxicam18$14
Amoxicillin15$11

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →